Delivery Order SPE2DB20D6036-SPE2DB24FC8PB
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,867.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of QSYMIA 7.5 MG-46 MG capsules, a prescription medication, to support federal healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other agencies, such as the Department of Justice Federal Bureau of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,855.40, is a firm fixed-price delivery order for the supply of QSYMIA 15 MG-92 MG CAPSULE 30S. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $2,749.53, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565005270 - QSYMIA 15 MG-92 MG CAPSULE 30S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a...
This federal contract award, with a ceiling value of $2,073.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,598.38, is for the supply of pharmaceutical products, specifically QSYMIA 3.75 MG-23 MG capsules. The contract has a Firm Fixed Price pricing type and an ultimate completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,466.30, is for the delivery of the prescription medication QSYMIA 3.75 MG-23 MG CAPSULE 30S. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific pharmaceutical product, QSYMIA 3.75 MG-23 MG CAPSULE 30S, with a ceiling value of $1,110.96 and a completion date of June 4, 2025. The contract type is Firm Fixed Price. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with an ultimate completion date of June 10, 2025 and a ceiling value of $1,032.01. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...